× Industry Reports Services Press Release Contact us About us

North America In Vitro Diagnostics (IVD) Market Forecast 2027 By End-Use (Hospitals, Diagnostic Laboratories, Academic & Research Institutes), By Product Type (Reagents & Kits, Instruments), By Test Type (Clinical Chemistry, Immunoassay/ Immunochemistry, Molecular Diagnostics, Hematology, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/Pharmacogenomics), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
Published Date: January 2022 | Publisher: Graphical Research Report ID: GR1033 | Delivery : PDF  Request Free Sample

Report Content

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definitions

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.3    References & sources

1.3.1    Secondary

1.3.2    Primary

Chapter 2   Executive Summary

2.1    North America in vitro diagnostics industry summary, 2016 – 2027

2.1.1    Business trends

2.1.2    Product type trends

2.1.3    Test type trends

2.1.4    Application trends

2.1.5    End-use trends

2.1.6    Regional trends

Chapter 3   Industry Insights

3.1    Industry segmentation

3.2    Industry outlook, 2016 – 2027

3.3    Major factor analysis

3.3.1    Growth drivers

3.3.1.1    Rising prevalence of infectious and chronic diseases

3.3.1.2    Growing adoption of personalized medicine

3.3.1.3    Increasing adoption of point of care testing

3.3.1.4    Surging number of pathology labs and services equipped with advanced diagnostics machine

3.3.1.5    Increasing R&D activities in in-vitro diagnostics industry

3.3.2    Restraints & challenges

3.3.2.1    High cost of diagnostic services

3.3.2.2    Unfavorable reimbursement scenario

3.4    COVID-19 impact analysis

3.5    Porter’s analysis

3.6    Competitive review, 2020

3.7    PEST analysis

Chapter 4   North America In Vitro Diagnostics Market, By Product Type

4.1    Key trends in North America in vitro diagnostics market, by product type

4.2    Reagents & Kits

4.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

4.3    Instruments

4.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

Chapter 5   North America In Vitro Diagnostics Market, By Test Type

5.1    Key trends in North America in vitro diagnostics market, by test type

5.2    Clinical chemistry

5.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.3    Immunoassay/Immunochemistry

5.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.4    Molecular diagnostics

5.4.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.5    Hematology

5.5.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.6    Urinalysis

5.6.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.7    Others

5.7.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

Chapter 6   North America In Vitro Diagnostics Market, By Application

6.1    Key trends in North America in vitro diagnostics market, by application

6.2    Oncology

6.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.3    Infectious diseases

6.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.4    Diabetes

6.4.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.5    Cardiology

6.5.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.6    Nephrology

6.6.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.7    Autoimmune Diseases

6.7.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.8    Drug Testing/Pharmacogenomics

6.8.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.9    Others

6.9.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

Chapter 7   North America In Vitro Diagnostics Market, By End-use

7.1    Key trends in North America in vitro diagnostics market, by end-use

7.2    Hospitals

7.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

7.3    Diagnostic laboratories

7.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

7.4    Academic & research institutes

7.4.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

7.5    Others

7.5.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

Chapter 8   North America In Vitro Diagnostics Market, By Country

8.1    Key trends in North America in vitro diagnostics market, by country

8.1.1    U.S.

8.1.1.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.1.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.1.3    Market estimates and forecast, by application, 2016 – 2027

8.1.1.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.2    Canada

8.1.2.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.2.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.2.3    Market estimates and forecast, by application, 2016 – 2027

8.1.2.4    Market estimates and forecast, by end-use, 2016 – 2027

Chapter 9   Company Profiles

9.1    F. Hoffmann-La Roche AG

9.1.1    Business Overview

9.1.2    Financial data

9.1.3    Product landscape

9.1.4    Strategic outlook

9.2    Abbott

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.3    Danaher

9.3.1    Business Overview

9.3.2    Financial data

9.3.3    Product Landscape

9.3.4    Strategic outlook

9.4    Siemens Healthineers

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.5    BioMerieux

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.6    DiaSorin

9.6.1    Business Overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.7    Bio-Rad Laboratories

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.8    Sysmex Corporation

9.8.1    Business Overview

9.8.2    Financial data

9.8.3    Product Landscape

9.8.4    Strategic outlook

9.9    Thermo Fisher Scientific

9.9.1    Business Overview

9.9.2    Financial data

9.9.3    Product Landscape

9.9.4    Strategy outlook

9.10    Qiagen

9.10.1    Business Overview

9.10.2    Financial data

9.10.3    Product Landscape

9.10.4    Strategic outlook

9.11    Ortho Clinical Diagnostics

9.11.1    Business Overview

9.11.2    Financial data

9.11.3    Product Landscape

9.11.4    Strategic outlook

9.12    Becton, Dickinson and Company.

9.12.1    Business Overview

9.12.2    Financial data

9.12.3    Product Landscape

9.12.4    Strategic outlook
 


Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]